StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Alere (ALR) Announces Voluntary Withdrawal of INRatio, INRatio2 Monitoring Systems
July 11, 2016 5:31 PM
Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc. (NYSE: ALR) will be initiating ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Next Articles
Leerink Partners Remains Bullish as Alere (ALR) Withdraws INRatio and INRatio 2 Products
July 12, 2016 9:13 AM
Alere to Initiate Voluntary Withdrawal of the Alere INRatio® and INRatio®2 PT/INR Monitoring System
July 11, 2016 5:00 PM
